Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus

BACKGROUND: The pharmacokinetic properties of liraglutide, a glucagon-like peptide-1 receptor agonist approved for the treatment of type 2 diabetes mellitus (T2D), have been established in healthy individuals and subjects with T2D. Liraglutide has been under investigation as adjunct treatment to ins...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Pharmacokinet
Hauptverfasser: Mader, Julia K., Jensen, Lene, Ingwersen, Steen H., Christiansen, Erik, Heller, Simon, Pieber, Thomas R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2016
Schlagworte:
Short Communication
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069309/
https://ncbi.nlm.nih.gov/pubmed/27282158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-016-0413-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge